Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Mutat Res. 2010 Jan 8;686(1-2):1–8. doi: 10.1016/j.mrfmmm.2009.11.012

Table 2. Plasma cell neoplasms: determination of f and μ.

Cell line Starting # cells (× 10-6)* # days in culture CE** # cell divisions, d¶¶ # GPI(−) cells Total # cells analyzed§ Mutant frequency f (× 106) Mutation rate μ (× 107)‡‡
KMS-11 .38 22 0.56 6.74 5 1082484 4.62 6.9
ARP-1 2.0 33 0.66 5.35 3 539077 5.57 10.4
U266 6.3 33 0.69 5.00 62 1619500 38.3 76.6
SKMM2 1.6 22 1.0 4.51 2 2027237 0.99 2.2
NCI-H929 2.1 21 0.55 3.48 16 1235227 12.95 37.2
ARH-77 7.3 19 0.82 3.21 82 1736463 47.2 147
RMPI-8226 0.88 22 0.73 5.24 16 1487327 10.8 20.5
*

Number of GPI (+) cells collected by sorting, in millions

**

Cloning Efficiency in Bulk Culture

Number of days in culture between sorting and analysis

¶¶

Number of cell divisions occurring in culture between sorting and analysis

§

Number of cells in the upper right quadrant plus number of cells in the lower right quadrant

f = number of GPI (-) cells divided by total number of cells analyzed. Results expressed as mutants per 106 cells.

‡‡

Mutation rate calculated by the formula μ = f divided by d. Results expressed as mutations per 107 cell divisions